Q3 2019 EPS Estimates for SAGE Therapeutics Inc Raised by Piper Jaffray Companies (NASDAQ:SAGE)
SAGE Therapeutics Inc (NASDAQ:SAGE) – Piper Jaffray Companies lifted their Q3 2019 earnings per share estimates for shares of SAGE Therapeutics in a report issued on Tuesday, August 6th, according to Zacks Investment Research. Piper Jaffray Companies analyst D. Brill now anticipates that the biopharmaceutical company will post earnings per share of ($3.40) for the quarter, up from their previous forecast of ($3.47). Piper Jaffray Companies also issued estimates for SAGE Therapeutics’ Q4 2019 earnings at ($3.44) EPS, FY2019 earnings at ($13.51) EPS, Q1 2020 earnings at ($3.13) EPS, Q2 2020 earnings at ($3.22) EPS, Q3 2020 earnings at ($3.24) EPS, Q4 2020 earnings at ($3.37) EPS, FY2020 earnings at ($12.90) EPS, FY2021 earnings at ($9.74) EPS and FY2022 earnings at $0.51 EPS.
A number ...